Dr. Adam J. Smith, MD
Pulmonology (Pulmonary Disease Physician)
41 Mall Road, Lahey Hospital & Medical Center
Burlington, MA 01805
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 967
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2003Medical school: New York University School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
MA license 243091 -
Critical Care Medicine (Internal Medicine) Physician
MA license 243091
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Lahey Hospital & Medical Center, Burlington Burlington, MA
- Northeast Hospital Corporation Beverly, MA
- Anna Jaques Hospital Newburyport, MA
- Merrimack Health Lawrence Hospital Lawrence, MA
- Holy Family Hospital Methuen, MA
Medical groups
- Lahey Clinic Inc (1,381 clinicians)
- Incare LLC (60 clinicians)
- Incare Tufts PLLC (57 clinicians)
- Incare Lawrence, PLLC (21 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 967
- Services billed
- 2,042
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 594 | 385 |
| Test to examine how well the lungs exchange gases | 256 | 253 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 158 | 158 |
| New patient office or other outpatient visit, 45-59 minutes | 134 | 134 |
| Established patient office or other outpatient visit, 20-29 minutes | 131 | 119 |
| Test to measure expiratory airflow and volume | 110 | 107 |
| Test to determine lung volumes using sensors | 100 | 100 |
| Critical care, first 30-74 minutes | 84 | 50 |
| New patient office or other outpatient visit, 30-44 minutes | 63 | 63 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 47 | 35 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Burlington, MA | 584 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Burlington, MA | 476 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Burlington, MA | 253 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Burlington, MA | 244 |
| Prednisone Other prescribers in Burlington, MA | 170 |
| Wixela Inhub (fluticasone propion/salmeterol) Other prescribers in Burlington, MA | 134 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Burlington, MA | 119 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Burlington, MA | 118 |
| Montelukast Sodium Other prescribers in Burlington, MA | 115 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Burlington, MA | 111 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 94 payments worth $30,160 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $15,394 |
|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,899 |
| Verona Pharma, Inc. | $5,124 |
| Gyrus Acmi, Inc. | $1,412 |
| Amgen Inc. | $185 |
| Astellas Pharma US Inc | $51.24 |
| Regeneron Healthcare Solutions, Inc. | $43.99 |
| Insmed, Inc. | $31.89 |
| Consulting Fee | $12,938 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $7,693 |
| Honoraria | $4,800 |
| Travel and Lodging | $2,643 |
| Food and Beverage | $2,052 |
| Education | $34.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 5, 2025 | Consulting Fee | $6,510 |
| Verona Pharma, Inc. Nov 3, 2025 | Honoraria Ohtuvayre · Pulmonary/Respiratory Diseases | $2,800 |
| Verona Pharma, Inc. Dec 22, 2025 | Honoraria Ohtuvayre · Pulmonary/Respiratory Diseases | $2,000 |
| AstraZeneca Pharmaceuticals LP Sep 19, 2025 | Consulting Fee FASENRA · Respiratory | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 18, 2025 | Consulting Fee | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 22, 2025 | Consulting Fee BREZTRI · Respiratory | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| AstraZeneca Pharmaceuticals LP Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
All 30 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Verona Pharma, Inc. Dec 22, 2025 | Honoraria Ohtuvayre · Pulmonary/Respiratory Diseases | $2,000 |
| Verona Pharma, Inc. Dec 22, 2025 | Compensation for services other than consulting (speaking, faculty) Ohtuvayre · Pulmonary/Respiratory Diseases | $72.80 |
| AstraZeneca Pharmaceuticals LP Nov 11, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,320 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 5, 2025 | Consulting Fee | $6,510 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 5, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $140 |
| Verona Pharma, Inc. Nov 3, 2025 | Honoraria Ohtuvayre · Pulmonary/Respiratory Diseases | $2,800 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 27, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $183 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,850 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX Company’s descriptionConsulting Expenses | $182 |
| AstraZeneca Pharmaceuticals LP Sep 23, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Sep 22, 2025 | Consulting Fee BREZTRI · Respiratory | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 19, 2025 | Consulting Fee FASENRA · Respiratory | $1,860 |
| AstraZeneca Pharmaceuticals LP Sep 18, 2025 | Consulting Fee | $1,860 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 17, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 16, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $374 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 16, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $210 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $347 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $284 |
| AstraZeneca Pharmaceuticals LP Sep 12, 2025 | Travel and Lodging BREZTRI · Respiratory · travel to Dallas, TX · in-kind Company’s descriptionSpeaker Expenses | $57.61 |
| Amgen Inc. Sep 11, 2025 | Education in-kind | $34.00 |
| AstraZeneca Pharmaceuticals LP Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Jul 25, 2025 | Travel and Lodging FASENRA · Respiratory · travel to North Andover, MA · in-kind Company’s descriptionSpeaker Expenses | $28.00 |
| AstraZeneca Pharmaceuticals LP Jul 22, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Boston, MA · in-kind Company’s descriptionSpeaker Expenses | $25.35 |
| Gyrus Acmi, Inc. Jun 10, 2025 | Consulting Fee MEDICAL CONTROL UNIT FOR ENDOSURGERY UCES-4 · Audio, Video, Imaging | $848 |
| Gyrus Acmi, Inc. Jun 10, 2025 | Travel and Lodging MEDICAL CONTROL UNIT FOR ENDOSURGERY UCES-4 · Audio, Video, Imaging · travel to Westborough, MA · in-kind | $564 |
| AstraZeneca Pharmaceuticals LP Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $125 |
| AstraZeneca Pharmaceuticals LP Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) FASENRA · Respiratory Company’s descriptionSpeaker Fee | $1,400 |
| AstraZeneca Pharmaceuticals LP Feb 28, 2025 | Travel and Lodging FASENRA · Respiratory · travel to North Andover, MA · in-kind Company’s descriptionSpeaker Expenses | $29.40 |
| AstraZeneca Pharmaceuticals LP Feb 26, 2025 | Travel and Lodging FASENRA · Respiratory · travel to Lawrence, MA · in-kind Company’s descriptionSpeaker Expenses | $42.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.